Dynamic Atom Clusters for AGE Breakdown via Free Radical Response

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Chronic diseases, particularly those associated with advanced glycation end products (AGEs), are challenging to treat due to the diverse chemical nature of AGEs and their formation of free radicals, which disrupt bodily functions and are difficult to target with conventional drugs.

Innovation Solution

Dynamic clusters of atom particles are constructed at body temperature, allowing them to detach and respond to highly reactive free radicals, targeting AGEs and restoring bodily functions by separating sugars and disintegrating the AGE layer by layer.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional drugs are designed to bind to AGEs, then specific targeting of AGEs is achieved, but the diverse chemical nature of AGEs makes drug design challenging and impracticable

Engineering Contradiction:
Improvetargeting effectivenessVSAvoiddrug design complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent employs a universal approach by using dynamic clusters of atom particles that can interact with AGEs through non-specific physical-chemical mechanisms rather than requiring specific molecular binding. The clusters contain multiple elements (alkali metals, alkaline earth metals, transition metals, etc.) that provide a wide range of intrinsic properties to respond to free radicals of diverse chemical nature, making the treatment applicable to AGEs regardless of their specific chemical structure.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent changes the physical-chemical parameters of the treatment approach by using dynamic clusters with adjustable composition and properties. The clusters can be tailored with different elemental compositions, sizes, and structures to optimize their interaction with free radicals. This parameter-based approach replaces the need for specific molecular recognition, simplifying the treatment design while maintaining effectiveness against diverse AGEs.

Inventive Principle:
Principle #35Parameter changes

2Object-affected harmful factors

If drugs are designed to target free radicals, then the harmful effects of free radicals can be counteracted, but free radicals feature high reactivity which enables them to easily bind and cause damages to molecules around them

Engineering Contradiction:
Improvefree radical damageVSAvoidfree radical reactivity
Core Design Contradiction:
Object-affected harmful factorsVSObject-generated harmful factors

Solution Approach 1:

The patent introduces dynamic clusters of atom particles as intermediaries between the treatment system and free radicals. These clusters do not directly neutralize free radicals through chemical binding but rather interact with them through physical-chemical mechanisms such as electromagnetic field interactions and energy transfer. The clusters serve as mediators that can respond to free radicals without being immediately consumed or causing additional damage, thereby reducing free radical harm while avoiding the pitfalls of direct high-reactivity interactions.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent converts the high reactivity of free radicals, which normally causes damage, into a beneficial effect by designing dynamic clusters that can detect and respond to the irregularities caused by free radicals. The clusters utilize the presence of free radicals as a signal to activate and detach atom particles that can then interact with the free radicals in a controlled manner, transforming the harmful reactivity into a detectable and manageable phenomenon.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Speed

If dynamic clusters are made small to flow through capillaries, then mobility is improved, but the clusters must remain loosely clustered to allow easy detachment of atom particles at body temperature

Engineering Contradiction:
Improvecluster mobilityVSAvoidcluster structure stability
Core Design Contradiction:
SpeedVSStability of the object's composition

Solution Approach 1:

The patent applies the dynamics principle by creating clusters with adjustable stability that can adapt to different conditions. The dynamic clusters are designed to maintain their structure during transport through the bloodstream but can detach atom particles when encountering free radicals or under specific conditions such as changes in electromagnetic field, temperature, or chemical environment. This dynamic behavior allows the clusters to fulfill both requirements: remaining mobile enough to reach target sites while maintaining sufficient structural integrity for transport and controlled disassembly for action.

Inventive Principle:
Principle #15Dynamics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The dynamic clusters effectively reduce AGEs, restoring bodily functions and making sugars usable, as demonstrated by reduced AGE peptide levels in treated diabetic mice, indicating reversible AGE formation.

Implementation Method 1

construction of dynamic clusters from selected atoms through electromagnetic field and flow velocity adjustment

Methodology Applied
Scientific EffectElectromagnetic field interaction: Electromagnetic Induction

Implementation Method 2

The detached atom particles, at the appropriate frequencies, become entangled with the AGEs which emit free radicals, separating sugars while disintegrating the rest layer by layer

Methodology Applied
Scientific EffectResonance: Resonance

Data Source

PatentUS12533319B2Dynamic clusters of atom particles activated in extracellular fluid
Publication Date: 2026.01.27 SEAWAGEN RESEARCH INSTITUTE ZHENGZHOU
  • US12533319B2 patent drawing

AI summary

Provided herein are dynamic clusters of atom particles activated in extracellular fluid intended to reverse the accumulation of advanced glycation end products which are closely related to chronic diseases. The manufacturing process involves material preparation, particle fragmentation, pH adjustment, selection of atom particles and construction of dynamic clusters through electromagnetic field and flow velocity adjustment, and separation of dynamic clusters from the liquid. The dynamic clusters of atom particles deal with advanced glycation end products, which are diverse in chemical nature, by responding to irregularities in the electromagnetic field disrupted by highly reactive free radicals advanced glycation end products emit. Such mechanism makes it possible to extend the applications to diseases related to irregular free radical activities other than chronic diseases like in HIV replication or neural signalling.